Rational anticoagulant therapy during pregnancy

Mel'nikov A.P.; Petrukhin V.A.; Polovinkina I.A.

doi:https://doi.org/

Mel'nikov A.P.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Petrukhin V.A.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Polovinkina I.A.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Rational anticoagulant therapy during pregnancy

Authors:

Mel'nikov A.P., Petrukhin V.A., Polovinkina I.A.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2010;10(1): 23‑28

Read: 28320 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Mel'nikov AP, Petrukhin VA, Polovinkina IA. Rational anticoagulant therapy during pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2010;10(1):23‑28. (In Russ.)

Подписка 2026 Российский вестник акушера-гинеколога (Russian Bulletin of Obstetrician-Gynecologist)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Peculiarities of placental microRNA expression in patients with preeclampsia and fetal growth restriction. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):14-25

Changes in the type of psychological component of the gestational dominant in pregnant women in the third trimester after completing the perinatal preparation program. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):66-71

Assessment of risk factors for breast cancer development in women living in the Saratov region. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):100-106

Sexual function of women during pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):112-117

Local cytokine profile of the endometrium in patients with repeated implantation failures and its pharmacological correction by the secretome of peripheral blood mononuclear cells. Russian Journal of Human Reproduction. 2024;(5):46-54

Immunological aspects of reccurent pregnancy loss. Russian Journal of Human Reproduction. 2024;(5):64-71

Dynamics of Substance P and Filaggrin Levels on Combined Treatment of Atopic Dermatitis with Emollient and Topical Antipruritic Drug in Pregnant Women. Russian Journal of Clinical Dermatology and Venereology. 2024;(6):662-666

Functional cytokine redundancy in pregnancy. Russian Journal of Human Reproduction. 2024;(6):73-80

Clinical case of successful pregnancy in a patient with ectopic ACTH syndrome after radical surgical treatment. Russian Journal of Human Reproduction. 2024;(6):118-123

Diabetic retinopathy and pregnancy. Russian Annals of Ophthalmology. 2024;(6):145-151

Abstract:

The overview gives updated data on the administration routes of anticoagulants that are most frequently used in obstetric care. It outlines principles in the use of rational heparin therapy during pregnancy and labor and those in the laboratory monitoring of performed treatment.

Keywords:

pregnancy

labor

anticoagulant therapy

Authors:

Mel'nikov A.P.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Petrukhin V.A.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Polovinkina I.A.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Close metadata

References:

Abildgaard U., Segadal L., Hammerstrøm J. et al. Mechanical prosthetic valves and pregnancy: prophylaxis with dose adjusted LMW heparin in 12 pregnancies. Thromb Res 2007; 119: Suppl 1: 106-107.
Aldea M.J., Gavrilut M., Gaba A. et al. Venous thrombosis and pregnancy. XVIII FIGO World Congress of Gynecology and Obstetrics. Abstract Book: Book 2. Kuala Lumpur, Malasia 2006; 87-88.
Andersen A.S., Bergholt T.,Berthelsen J.G. Low molecular weight heparin (LMWH) and pregnancy. Thromb Res 2007; 119: Suppl
Ansell G. Factor Xa or thrombin: is factor Xa a better target? J Thromb Haemost 2007; 5: suppl 1: 60-64.
Bombeli Th., Raddatz-Mueller P., Fehr J. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women. Am J Obstet Gynec 2001; 184: 5: 382-389.
Brenner B. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications – Yes. J Thromb Haemost 2003; 1: 2070-2072.
Butt M.S., Jowett N.I., Haq S. Deep vein thrombosis prophylaxis in medical inpatients. Clin Med 2007; 7: 4: 418-419.
Damodaran M., Kalidindi M., Madipola S. et al. Suspected pulmonary embolism in pregnancy - difficulties in diagnosis & adverse pregnancy outcome after treatment with low molecular weight heparin. XVIII FIGO World Congress of Gynecology and Obstetrics. Abstract Book: Book 3. Kuala Lumpur, Malasia 2006; 59.
Damodaran M., Kalidindi M., Madipola S. et al. Suspected pulmonary embolism in pregnancy – is D-dimer testing of any benefit? XVIII FIGO World Congress of Gynecology and Obstetrics. Abstract Book: Book 4. Kuala Lumpur, Malasia 2006; 176.
Dubedal I., Bjørge L., Majak P. et al. Pregnancy and severe thrombophilia: 35 pregnancies in hereditary antithrombin deficient women in Norway. Thromb Res 2007; 119: Suppl 1: 104.
Ginsberg J.S., Bates S.M. Management of venous thromboembolism during pregnancy. J Thromb Haemost 2003; 1: 7: 1435-1442.
Greer I.A. Risk factors and diagnosis of VTE in pregnancy. Thromb Res 2007; 119: Suppl 1: 8.
Jacobsen A.F., Sandset P.M. Management of venous thromboembolism (VTE) in pregnancy. Thromb Res 2007; 119: Suppl 1: 12-13.
Jacobsen A.F., Sandset P.M., Skjeldestad F.E. Incidence and risk factors of ante- and post-natal venous thromboembolism in pregnancy (VIP study). Thromb Res 2007; 119: Suppl 1: 107.
Khasia K.M., Reyad M. Low molecular weight heparin and monitoring of anti-Xa levels during pregnancy. XVIII FIGO World Congress of Gynecology and Obstetrics. Abstract Book: Book 4. Kuala Lumpur, Malasia 2006; 88.
Lambert J.R., Austin S.K., Peebles D. Audit of the peri-delivery use of unfractionated heparin in women on therapeutic low-molecular weight heparin. Br J Haemat 2008; 142: 3: 53-56.
Murayama I., Seki H., Baba K., Takeda S. A clinical study of management of pregnant Japanese women complicated by venous thromboembolism. XVIII FIGO World Congress of Gynecology and Obstetrics. Abstract Book: Book 4. Kuala Lumpur, Malasia 2006; 185.
Musset D., Parent F., Meger G. et al. Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study. Lancet 2002; 360: 9349: 1914-1920.
Preston F.E., Walker I.D., Rosendaal F.R. et al. Increased fetal loss in women with thrombophilia. Br J Haemat 1996; 93: Suppl 1: 5.
Qaddoumi B., Abu Adas A. Tit/anticoagulant therapy in pregnant women with valve replacement: maternal and fetal outcome SLE. XVIII FIGO World Congress of Gynecology and Obstetrics. Abstract Book: Book 3. Kuala Lumpur, Malasia 2006; 58.
Rohathi M. Efficacy of anticoagulants in recurrent pregnancy loss with antyphospholipid syndrome in high risk pregnancy clinic. XVIII FIGO World Congress of Gynecology and Obstetrics. Abstract Book: Book 3. Kuala Lumpur, Malasia 2006; 58.
Samama M.M., Desnoyers P., Gerotziafas G.T. Low molecular weight heparins: a comparative review of pharmacodynamics, clinical pharmacology. Thrombosis and antithrombotic therapy. Ed. G. Lugassy, M. Dunitz. Ltd 2001; 71-96.
Schulman S. Unresolved issues in anticoagulant therapy. J Thromb Haemost 2003; 1: 7: 1464-1470.
Schulman S. Inherited thrombophylia. Thrombosis and antithrombotic therapy. Ed. G. Lugassy, M. Dunitz. Ltd 2001; 21-36.
de Swiet M. Management of pulmonary embolus in pregnancy. Europ Heart J 1999; 20: 19: 1378-1385.